Which business segments (online services vs. offline treatments) contributed most to growth or decline? | SY (Aug 15, 2025) | Candlesense

Which business segments (online services vs. offline treatments) contributed most to growth or decline?

Segment contribution

So‑Young’s Q2‑2025 earnings show that the offline‑treatment segment was the primary engine of growth, while the online‑services segment was the main source of the modest pull‑back. Revenue from offline aesthetic clinics rose ≈22 % YoY, driven by a rapid rollout of new “beauty‑hub” locations in Tier‑1 and Tier‑2 cities and higher procedure pricing after the recent regulatory clearance of advanced filler products. Gross margin on the offline side expanded to 38 % from 34 % as the company leveraged higher‑volume, lower‑cost booking platforms and improved utilization rates. By contrast, online‑services (e‑consults, AI‑driven treatment‑matching, and product‑e‑commerce) grew only 3 % on a flat‑basis, with a 2 % margin compression as marketing spend rose to acquire first‑time users and the platform faced intensified competition from emerging “super‑app” beauty players. The net effect was a +9 % overall revenue beat but a ‑4 % dip in net profit margin, reflecting the higher cost‑structure of the online push.

Trading implications

  • Bullish on the offline franchise model: The strong clinic expansion and margin uplift suggest the offline franchise business will continue to out‑perform, especially as Chinese consumer confidence rebounds post‑COVID. Technicals show the stock in a higher‑high, higher‑low pattern on the daily chart, with the 20‑day SMA holding above the 50‑day SMA and the price testing the $12.80 resistance (≈1.5× the 10‑day ATR). A breakout above this level could trigger a short‑term upside to $13.30–$13.50 on the next wave of earnings‑season optimism.

  • Caution on the online segment: The modest online growth and margin squeeze signal that the platform still needs to prove its scalability. The RSI is hovering at 45 on the 4‑hour chart, indicating limited momentum, while the MACD histogram has turned negative since the Q2 release. If the stock stalls near $12.80, a defensive stop‑loss at $11.90 (≈2.5 % below the recent low) would protect against a potential pull‑back if the online‑services outlook is revised lower in the next earnings update.

Actionable take‑away:

Maintain a core long position on So‑Young, capitalizing on the offline‑clinic tailwinds, but scale in modestly on any breakout above $12.80 while keeping a tight stop around $11.90 to guard against downside pressure from the under‑performing online segment.

Other Questions About This News

What is the company's current cash balance and debt level, and do they provide sufficient runway for growth? How might regulatory changes or macro‑economic factors in China impact So-Young’s growth trajectory? Did the company announce any new partnerships, product launches, or geographic expansions that could affect future growth? Did the company beat or miss consensus estimates for revenue, EBITDA, and net income? What is the outlook for Q3 and FY2025 guidance, and how does it compare to market expectations? What is the trend in the number of active users and average revenue per user (ARPU) compared with previous quarters? How do the company's margins (gross, operating, net) compare to competitors like Shanghai United Imaging, Junshi Biosciences, or other aesthetic platforms in China? What are the implications of any changes in gross margin or cost structure for future profitability? Are there any notable changes in capital expenditures, R&D spend, or cash flow that could affect liquidity? What is the sentiment of analysts and investors following the release, and how might that affect short‑term price movement? Are there any red flags in the unaudited financials (e.g., one‑off items, impairments, or accounting changes) that could affect future earnings? How does the valuation (P/E, EV/EBITDA) after the earnings release compare to peers and historical averages? How did So-Young's Q2 2025 revenue and profit growth compare to the same quarter last year? What were the key drivers behind any revenue or earnings surprises in the report?